Literature DB >> 16770160

Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use.

Eva Christina Kim1, C Stephen Foster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770160     DOI: 10.1097/00004397-200604620-00013

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  7 in total

Review 1.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Emerging drugs for uveitis.

Authors:  Theresa Larson; Robert B Nussenblatt; H Nida Sen
Journal:  Expert Opin Emerg Drugs       Date:  2011-01-06       Impact factor: 4.191

3.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

4.  A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor.

Authors:  Joonhong Sohn; Ju Byung Chae; Sun Young Lee; Soo-Youl Kim; June-Gone Kim
Journal:  Korean J Ophthalmol       Date:  2010-02-05

5.  Comparative efficacy of steroid-sparing therapies for non-infectious uveitis.

Authors:  Jared E Knickelbein; Meredith Kim; Elvira Argon; Robert B Nussenblatt; Nida H Sen
Journal:  Expert Rev Ophthalmol       Date:  2017-04-26

6.  Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)-report 4: analysis and outcome of scleritis in an East Asian population.

Authors:  Muhammad Amir Bin Ismail; Rachel Hui Fen Lim; Helen Mi Fang; Elizabeth Poh Ying Wong; Ho Su Ling; Wee Kiak Lim; Stephen C Teoh; Rupesh Agrawal
Journal:  J Ophthalmic Inflamm Infect       Date:  2017-02-15

7.  Infliximab for the treatment of refractory scleritis.

Authors:  Priyanka Doctor; Amyna Sultan; Sana Syed; William Christen; Pooja Bhat; C Stephen Foster
Journal:  Br J Ophthalmol       Date:  2009-12-02       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.